Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Laboratory for Molecular Medicine, |
RCV000039750 | SCV000063439 | likely benign | not specified | 2012-01-10 | criteria provided, single submitter | clinical testing | Ala1761Ala in exon 33 of PCDH15: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. |
| Illumina Laboratory Services, |
RCV000264922 | SCV000363125 | uncertain significance | Usher syndrome type 1 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
| Labcorp Genetics |
RCV001497321 | SCV001702047 | likely benign | not provided | 2024-02-14 | criteria provided, single submitter | clinical testing | |
| Natera, |
RCV001826583 | SCV002076937 | likely benign | Usher syndrome type 1F | 2020-08-13 | no assertion criteria provided | clinical testing |